KBR Selected as Key Commercialization Partner for Samsara Eco's First-of-a-Kind Enzymatic Recycling Plant
HOUSTON, April 29, 2025 (GLOBE NEWSWIRE) -- KBR (NYSE: KBR) announced today it will support biotech innovator, Samsara Eco, to design its first-of-a-kind plastics and textile enzymatic recycling plant, due for completion in early 2028.
Samsara Eco's enzymatic recycling technology aims to create a continuous recycling loop for some of the most common types of plastic and synthetic fiber – materials that have traditionally been difficult or impossible to recycle. Powered by Samsara Eco's proprietary AI platform, the company's patented enzymes break down plastic to its original building blocks (monomers) which aim to allow plastics to be continuously remanufactured into new products without degradation in quality and with a low carbon footprint. Unlike other recycling methods, Samsara Eco's technology has demonstrated the recycling of notoriously difficult plastics, including nylon 6,6 and mixed fibers, as well as colored and dyed fabric blends. This breakthrough technology is expected to be critical towards achieving the goal of creating a circular loop for all plastics recycling, helping companies utilize resources and divert waste otherwise destined for landfills.
Under the terms of the agreement, KBR will perform a pre-FEED (front-end engineering design) of the project by the end of Q2 2025. KBR's technical and commercial experts will then deliver a FEED engineering package for the process design to build a 20,000 metric tons per year commercial facility for nylon 6,6.
'KBR is uniquely equipped to deliver world-class solutions that help our customers bring sustainable technology to market, and we are thrilled to support Samsara Eco on this unique opportunity,' said Jay Ibrahim, President, KBR Sustainable Technology Solutions. 'With this award, KBR continues to solidify our commitment to sustainability and technological innovation.'
Paul Riley, Founder and CEO of Samsara Eco commented, 'We are charging full speed ahead to deliver our first-of-a-kind plant to fuel a circular economy and support our brand partners' ambition to create more circular products from low-carbon recycled materials. KBR brings unmatched engineering expertise. This will ensure we can design and build our facility with speed and precision. We're proud to have KBR in our corner, helping to bring our technology to industrial scale.'
Samsara Eco is already working with leading brands including lululemon to swap virgin materials for recycled materials. Last year, it debuted the world's first enzymatically recycled nylon 6,6 product. It also launched the first product made from enzymatically recycled polyester, creating lululemon's limited edition Packable Anorak jacket.
At KBR, a more sustainable future begins now.
About KBRWe deliver science, technology and engineering solutions to governments and companies around the world. KBR employs approximately 38,000 people worldwide with customers in more than 80 countries and operations in over 29 countries. KBR is proud to work with its customers across the globe to provide technology, value-added services, and long-term operations and maintenance services to ensure consistent delivery with predictable results. At KBR, We Deliver.
Visit www.kbr.com
About Samsara EcoSamsara Eco is an Australian biotech on a mission to repair our planet through infinite plastic recycling. With our enzymatic recycling technology, EosEco™, we break down plastics and textiles to their original building blocks so they can be recreated into new products, infinitely. Our aim is to create a truly circular loop for plastics and textiles to reduce waste and the world's reliance on climate-damaging fossil fuels.
Samsara Eco launched in 2021 in partnership with the Australian National University (ANU), and with backing from Main Sequence and the Woolworths Group. It has raised over AUD $150M from its growing supporters including Temasek, Breakthrough VIC, Greycroft, DCVC, CEFC, lululemon, Hitachi Ventures, Titanium Ventures and Wollemi. In 2024, Samsara Eco created apparel with lululemon, including the world's first enzymatically recycled nylon 6,6 product. In 2025, it was named one of Fast Company's Most Innovative Companies.
Visit www.samsaraeco.com
Forward Looking Statements
The statements in this press release that are not historical statements, including statements regarding future effectiveness and adoption of technologies or processes and project outcomes, are forward-looking statements within the meaning of the federal securities laws. These statements are subject to numerous risks, uncertainties and assumptions, many of which are beyond the company's control, that could cause actual results to differ materially from the results expressed or implied by the statements. These risks, uncertainties and assumptions include, but are not limited to, those set forth in the company's most recently filed Annual Report on Form 10-K, any subsequent Form 10-Qs and 8-Ks and other U.S. Securities and Exchange Commission filings, which discuss some of the important risks, uncertainties and assumptions that the company has identified that may affect its business, results of operations and financial condition. Due to such risks, uncertainties and assumptions, you are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date hereof. Except as required by law, the company undertakes no obligation to revise or update publicly any forward-looking statements for any reason.
For further information, please contact:
Jamie DuBrayVice President, Investor Relations713-753-5082Investors@kbr.com
Philip IvyVice President, Global Communications and Marketing 713-753-3800MediaRelations@kbr.comSign in to access your portfolio
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
26 minutes ago
- Yahoo
3 Stocks Investors May Be Undervaluing By Up To 43.5%
The United States market has shown a positive trend, climbing 1.6% in the last week and rising 12% over the past year, with earnings projected to grow by 14% annually. In this environment, identifying stocks that are potentially undervalued can offer investors opportunities to capitalize on future growth while benefiting from current market conditions. Name Current Price Fair Value (Est) Discount (Est) Quaker Chemical (NYSE:KWR) $105.85 $210.37 49.7% KBR (NYSE:KBR) $55.45 $108.68 49% Horizon Bancorp (NasdaqGS:HBNC) $15.69 $30.69 48.9% Flowco Holdings (NYSE:FLOC) $19.17 $37.91 49.4% Curbline Properties (NYSE:CURB) $23.62 $47.17 49.9% Constellation Brands (NYSE:STZ) $192.91 $385.37 49.9% Array Technologies (NasdaqGM:ARRY) $7.265 $14.21 48.9% FinWise Bancorp (NasdaqGM:FINW) $14.85 $29.22 49.2% TransMedics Group (NasdaqGM:TMDX) $122.10 $238.94 48.9% Mobileye Global (NasdaqGS:MBLY) $15.72 $31.08 49.4% Click here to see the full list of 170 stocks from our Undervalued US Stocks Based On Cash Flows screener. Here we highlight a subset of our preferred stocks from the screener. Overview: Grab Holdings Limited operates as a superapp provider in Southeast Asia, offering a range of services including transportation, food delivery, and digital payments across countries such as Cambodia, Indonesia, Malaysia, Myanmar, the Philippines, Singapore, Thailand, and Vietnam; it has a market cap of approximately $20.72 billion. Operations: The company's revenue segments include Mobility at $1.08 billion, Deliveries at $1.56 billion, and Financial Services at $273 million. Estimated Discount To Fair Value: 37.5% Grab Holdings is trading at US$5.08, below its estimated fair value of US$8.13, presenting a potential undervaluation based on cash flows. The company recently reported a net income of US$10 million for Q1 2025, turning profitable from a previous net loss. While expected revenue growth is moderate at 14.1% annually, earnings are forecasted to grow significantly at over 40% per year, suggesting strong future cash flow potential despite low return on equity forecasts. The growth report we've compiled suggests that Grab Holdings' future prospects could be on the up. Dive into the specifics of Grab Holdings here with our thorough financial health report. Overview: Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company specializing in RNA-targeted therapeutics and gene therapies for rare diseases, with a market cap of approximately $3.58 billion. Operations: The company's revenue primarily comes from its activities in discovering, developing, manufacturing, and delivering therapies, totaling $2.23 billion. Estimated Discount To Fair Value: 43.5% Sarepta Therapeutics is trading at US$37.94, significantly below its estimated fair value of US$67.11, indicating potential undervaluation based on cash flows. Despite a volatile share price and revised revenue guidance for 2025 between US$2.3 billion to US$2.6 billion, the company shows strong growth prospects with earnings expected to increase by 48% annually and profitability anticipated within three years, driven by advancements in their gene therapy portfolio including ELEVIDYS for Duchenne muscular dystrophy. The analysis detailed in our Sarepta Therapeutics growth report hints at robust future financial performance. Click to explore a detailed breakdown of our findings in Sarepta Therapeutics' balance sheet health report. Overview: Jabil Inc. offers manufacturing services and solutions globally, with a market cap of approximately $18.01 billion. Operations: Jabil's revenue segments include Electronics Manufacturing Services at $21.98 billion and Diversified Manufacturing Services at $14.79 billion, reflecting its global reach in providing comprehensive manufacturing solutions. Estimated Discount To Fair Value: 26% Jabil is trading at US$167.44, below its estimated fair value of US$226.34, pointing to potential undervaluation based on cash flows. While earnings are forecast to grow significantly at 30.3% annually, profit margins have decreased from last year due to large one-off items affecting results. The company's high debt level is a concern, but strategic initiatives like the launch of advanced transceivers and board appointments bolster its growth trajectory in technology sectors. Insights from our recent growth report point to a promising forecast for Jabil's business outlook. Navigate through the intricacies of Jabil with our comprehensive financial health report here. Delve into our full catalog of 170 Undervalued US Stocks Based On Cash Flows here. Are any of these part of your asset mix? Tap into the analytical power of Simply Wall St's portfolio to get a 360-degree view on how they're shaping up. Enhance your investing ability with the Simply Wall St app and enjoy free access to essential market intelligence spanning every continent. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NasdaqGS:GRAB NasdaqGS:SRPT and NYSE:JBL. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
35 minutes ago
- Yahoo
Could Buying Visa Stock Today Set You Up for Life?
Favorable tailwinds support Visa's durable double-digit growth, which is set to continue in the years ahead. The company's massive ecosystem, consisting of cards and merchants, creates a powerful network effect. Shares aren't trading at a bargain valuation, so investors must set realistic expectations. 10 stocks we like better than Visa › We all want to find that one investment that can make us huge returns. In the past, Visa (NYSE: V) has done just that. The world's dominant payments processing entity has produced a total return of 2,880% since its initial public offering (IPO) in 2008. This means that had you been able to make a $10,000 investment in this top financial stock back then, you'd be staring at $298,000 in your portfolio today. Shares now trade in record territory. And the company's market cap is at $721 billion. But if you buy today, can Visa set you up for life? It might be obvious, but finding a business that has tremendous growth potential, particularly over the long term, can lead to strong investment gains. That's not a shocker. To be clear, though, Visa doesn't fall into this category anymore. But that doesn't mean it's done growing. In fact, Visa registers durable growth, which is propelled by favorable tailwinds. The first growth driver is the ongoing war on cash, as consumers and businesses adopt digital and noncash transaction methodologies. While developed economies, like the U.S. and Canada, have less of an opportunity these days, emerging markets in Asia and Africa still have meaningful potential. Ongoing economic growth, which fuels spending, also benefits Visa. In the past 10 years, core personal consumption expenditures in the U.S. increased by 101%. Assuming the global economy continues to expand and is much larger decades from now, it's safe to say that Visa will gain. According to consensus analyst estimates, the company's revenue and earnings per share are expected to climb at compound annual rates of 10.2% and 12.6%, respectively, between fiscal 2024 and fiscal 2027. I think it's fair-minded to expect this type of pace in the years after as well. Besides durable growth, another reason for why Visa should be on every investor's watch list is because the company possesses an economic moat. It has built up a key sustainable competitive advantage that supports long-term success. Visa has an incredible network effect. There are 4.8 billion of its cards active across the world. And 150 million merchants worldwide accept these cards. Cardholders find tremendous value because of how widely accepted Visa is. And the same is true for merchants, as being plugged into the Visa network means they don't have to turn down customers and lose out on potential sales. The network effect also underscores just how difficult it would be for Visa's market position to get disrupted. Over the past decade, numerous fintech enterprises have popped up, with a focus on improving the user experience to make payments even more seamless. You would think that this trend would have a negative impact. However, Visa continues to grow its revenue, earnings, and reach. The payment platform is essential to the smooth functioning of the economy and the effortless movement of money between various stakeholders. This gives me confidence that Visa isn't going away anytime soon. Visa has produced monster returns since the IPO 17 years ago. And this is definitely an outstanding company that should be on the investing radar. But I don't believe the stock will set you up for life. To put it another way, future returns will bear little resemblance to past returns. The S&P 500 index's total return is better than Visa's in the past five years. And don't ignore valuation. The stock trades at a price-to-earnings ratio of 37.5. That's expensive, without a doubt. It reflects the market's appreciation for this business. I can still understand why investors might want to dollar-cost average into Visa shares. Just don't expect to generate life-changing wealth. Before you buy stock in Visa, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Visa wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $653,702!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $870,207!* Now, it's worth noting Stock Advisor's total average return is 988% — a market-crushing outperformance compared to 172% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 9, 2025 Neil Patel has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Visa. The Motley Fool has a disclosure policy. Could Buying Visa Stock Today Set You Up for Life? was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
40 minutes ago
- Yahoo
What Does Williams-Sonoma, Inc.'s (NYSE:WSM) Share Price Indicate?
Williams-Sonoma, Inc. (NYSE:WSM) saw a double-digit share price rise of over 10% in the past couple of months on the NYSE. Shareholders may appreciate the recent price jump, but the company still has a way to go before reaching its yearly highs again. With many analysts covering the large-cap stock, we may expect any price-sensitive announcements have already been factored into the stock's share price. However, what if the stock is still a bargain? Let's take a look at Williams-Sonoma's outlook and value based on the most recent financial data to see if the opportunity still exists. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. Good news, investors! Williams-Sonoma is still a bargain right now. According to our valuation, the intrinsic value for the stock is $206.35, but it is currently trading at US$154 on the share market, meaning that there is still an opportunity to buy now. What's more interesting is that, Williams-Sonoma's share price is quite volatile, which gives us more chances to buy since the share price could sink lower (or rise higher) in the future. This is based on its high beta, which is a good indicator for how much the stock moves relative to the rest of the market. Check out our latest analysis for Williams-Sonoma Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Although value investors would argue that it's the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. However, with a relatively muted profit growth of 6.2% expected over the next couple of years, growth doesn't seem like a key driver for a buy decision for Williams-Sonoma, at least in the short term. Are you a shareholder? Even though growth is relatively muted, since WSM is currently undervalued, it may be a great time to increase your holdings in the stock. However, there are also other factors such as capital structure to consider, which could explain the current undervaluation. Are you a potential investor? If you've been keeping an eye on WSM for a while, now might be the time to make a leap. Its future outlook isn't fully reflected in the current share price yet, which means it's not too late to buy WSM. But before you make any investment decisions, consider other factors such as the strength of its balance sheet, in order to make a well-informed buy. So while earnings quality is important, it's equally important to consider the risks facing Williams-Sonoma at this point in time. For example - Williams-Sonoma has 1 warning sign we think you should be aware of. If you are no longer interested in Williams-Sonoma, you can use our free platform to see our list of over 50 other stocks with a high growth potential. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
